Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HealthEquity (HQY)

HealthEquity ends Chief Commercial Officer Michael Fiore's employment without cause

Neutral Impact 3 of 5 leadership Written later

HealthEquity terminated Chief Commercial Officer Michael Fiore without cause, effective October 5, 2026, according to an 8-K filed October 9, 2026. The company said his duties will be redistributed among other members of management, and the filing does not name a replacement.

Key points

  • Termination without cause effective October 5, 2026
  • Responsibilities of the Chief Commercial Officer to be redistributed to other management team members
  • Severance and benefits follow the employment agreement, as detailed in the May 13, 2026 proxy statement, conditioned on a release of claims and continued compliance with restrictive covenants
  • Outstanding equity awards to be treated under the 2014 and 2024 Stock Incentive Plans and related award agreements

The filing

CompanyHealthEquity (HQY)
Form8-K, current report
Filed with the SECOct 9, 2026, 5:00 PM ET
Accession number0001104659-26-115084

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.